FCR or FR – which regimen is better for treating CLL?
What is the role for idelalisib and duvelisib in CLL?
Key considerations for mutation detection in CLL
Understanding the drivers behind disease with the 100,000 Genomes Project
An introduction to the HOVON-141 trial in patients with CLL